GAS7 and metastatic malignant neoplasm in the lymph nodes: To determine whether there was an association between GAS7 expression levels and clinical parameters in breast cancer patients, the mRNA samples from 38 pairs of primary and lymph node metastatic tumors, as well as commercial breast cancer tissue arrays, were analyzed by RT-qPCR and immunohistochemistry (IHC) assays, respectively.